COVID-19 update and vaccination in PLWH

In this webinar we will discuss:

  1. Testing: What is the role of rapid antigen tests?
  2. Treatment: What are the current guidelines and recommended therapies?
  3. Preventing Covid-19 Infection
  • Public Health Measures: Which responses have been the most effective?
  • Vaccines: Safety and efficacy
  • SARS-CoV-2 variants: How do they differ?

  • This webinar will be presented by:

    Dr. Peter Phillips
    Clinical Professor
    Division of Infectious Diseases, University of British Columbia

    The presentation will be followed by a discussion where participants will have the opportunity to ask questions and receive real-time responses from the presenter.


    Cost: Free registration.

    Please register for the webinar by

    clicking here.

    This event is accredited by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1 Mainpro+ credit.

    If you are unable to attend the live webinar it will be recorded and available for viewing on BC-CfE’s Education and Training website at: education.cfenet.ubc.ca/webinars.

    For questions related to this event please contact: education@bccfe.ca


    Event Details

    Days
    Hours
    Minutes
    Seconds
    Start Date
    End Date
    Event Category
    Attendees of the BC-CfE Learning Series will be able to:
    • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
    • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
    • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
    • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
    Scroll to Top

    The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025